Skip to main content AI for business Use cases Consumer goods Digital sovereignty Education Overview Power and utilities Oil and gas Mining Overview Banking Capital markets Insurance Overview Defense and intelligence Transportation and urban infrastructure Public health and social services Public safety and justice Public finance Overview Defense and intelligence Federal civilian State and local governments Cloud for US government AI for US government Overview Providers Payors Life sciences Health solutions Overview Industrial transformation Media and entertainment Overview Automotive Travel and transportation Retail Telecommunications Microsoft 365 Copilot AI agents at work Agent 365 Security for AI Copilot Studio Microsoft Foundry Microsoft Agent Factory Azure AI apps and agents Microsoft Marketplace Copilot+ PCs Microsoft Copilot Download the Copilot app Microsoft responsible AI Principles and approach Tools and practices Advancing sustainability Securing AI Data protection and privacy AI 101 AI learning hub Industry blog Microsoft Cloud blog Support for business Industry documentation

Jesper Bagh articles

Jesper Bagh headshot
Jesper Bagh
Global GxP Lead, World Wide Commercial Business, Pharma and Life Sciences
Published 
2 min read

Commitment to compliance in pharma and life sciences 

Over a year has gone by since the beginning of the global pandemic, and it’s clear that the pharmaceutical industry and COVID-19 vaccines are at the center of everyone’s attention. Calls for quick and rigorous development of a COVID-19 vaccine have given way to the equally important demand for rapid distribution.
English (United States)
Your Privacy Choices Opt-Out Icon Your Privacy Choices
Consumer Health Privacy Sitemap Contact Microsoft Privacy Manage cookies Terms of use Trademarks Safety & eco Recycling About our ads